Brazilian pharmacists to be fined for selling Prexige
This article was originally published in Scrip
Executive Summary
Pharmacists in Brazil caught sellingNovartis's Prexige (lumiracoxib) could be fined up to R$2 million ($1.2 million), the country's medicine's regulator ANVISAhas warned after the product was withdrawn there last month.